000			04854cam a2200733Ia 4500
001			ocn694733434
003			OCoLC
005			20171224115040.0
006			m o d
007			cr cn|||||||||
008			110103s2011 nyua ob 001 0 eng d
040			_aGW5XE _beng _epn _cGW5XE _dEBLCP _dOCLCQ _dMHW _dOCLCQ _dOCLCF _dOCLCQ _dE7B _dN$T _dRRP _dOCLCO _dYDXCP _dDEBSZ _dOCLCO _dDG1 _dOCLCO _dOCLCQ _dOCLCO _dOCLCQ _dDEBBG _dDG1
066			_c(S
019			_a698589443 _a748435289 _a771448200 _a798698956
020			_a9781441972163 _q(electronic bk.)
020			_a1441972161 _q(electronic bk.)
020			_a9781441972156 _q(electronic bk.)
020			_a1441972153 _q(electronic bk.)
029	1		_aAU@ _b000048771752
029	1		_aAU@ _b000049595547
029	1		_aDEBSZ _b430928793
029	1		_aGBVCP _b790038005
029	1		_aNZ1 _b13777845
029	1		_aNZ1 _b15921957
029	1		_aDEBBG _bBV043392620
035			_a(OCoLC)694733434 _z(OCoLC)698589443 _z(OCoLC)748435289 _z(OCoLC)771448200 _z(OCoLC)798698956
037			_a978-1-4419-7215-6 _bSpringer _nhttp://www.springerlink.com
050		4	_aRC280.O8 _bE44 2011
060		4	_a2011 B-194
060		4	_aWP 322
072		7	_aHEA _x039030 _2bisacsh
072		7	_aMED _x062000 _2bisacsh
082	0	4	_a616.99/465 _222
049			_aMAIN
245	0	0	_aEmerging therapeutic targets in ovarian cancer / _cStan Kaye [and others], editors.
260			_aNew York : _bSpringer Science+Business Media, LLC, _c©2011.
300			_a1 online resource (xiii, 291 pages) : _billustrations
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aPreface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.
520			_aThis book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
588	0		_aPrint version record.
650		0	_aOvaries _xCancer _xTreatment.
650	1	2	_aOvarian Neoplasms _xtherapy.
650	2	2	_aAntineoplastic Agents _xtherapeutic use.
650	2	2	_aDrug Design.
650	2	2	_aDrug Therapy _xtrends.
650		4	_aMedicine.
650		7	_aHEALTH & FITNESS _xDiseases _xCancer. _2bisacsh
650		7	_aMEDICAL _xOncology. _2bisacsh
650		7	_aOvaries _xCancer _xTreatment. _2fast _0(OCoLC)fst01049287
655		4	_aElectronic books.
700	1		_aKaye, Stanley B.
776	0	8	_iPrint version: _tEmerging therapeutic targets in ovarian cancer. _dNew York : Springer, ©2011 _z9781441972156 _w(OCoLC)702604723
856	4	0	_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118185537 _zWiley Online Library
880	0		_6505-00/(S _aSystemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs / Susana Banerjee, Michael A. Bookman, and Martin Gore -- Discovery of Novel Targets / John Farley and Michael J. Birrer -- Novel Anti-angiogenic Therapies in Ovarian Cancer / Jurjees Hasan and Gordon Jayson -- Targeting the AKT Pathway in Ovarian Cancer / Euan A. Stronach [and others] -- Inhibition of the Src Oncogene : Therapeutic Potential in Ovarian Carcinoma / Liz Y. Han and Anil K. Sood -- Tumour-Specific Synthetic Lethality : Targeting BRCA Dysfunction in Ovarian Cancer / Timothy A. Yap [and others] -- Targeting Inflammatory Pathways in Epithelial Ovarian Cancer / Jermaine Coward and Frances Balkwill -- Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer : Moving Forward in the Era of Molecularly Targeted Therapy / Lainie P. Martin, Julia J. Perkins, and Russell J. Schilder -- Epigenetic Therapies / Robert Brown, Nadine Chapman-Rothe, and Ros Glasspool -- Ovarian Cancer Immunology and Immunotherapy / Sadaf Ghaem-Maghami and Martin Gore -- Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential / Susan K. Murphy and Andrew Berchuck -- Potential for α-Folate Receptor-Targeted Treatment for Ovarian Cancer / Chau H.M. Ng and Ann L. Jackman -- New Insights into Tubulin Binders / Carles Escriu and James D. Brenton.
938			_aEBL - Ebook Library _bEBLB _nEBL645306
938			_aebrary _bEBRY _nebr10432326
938			_aEBSCOhost _bEBSC _n371375
938			_aYBP Library Services _bYANK _n3547519
994			_a92 _bDG1
999			_c14341 _d14341